Filing Details

Accession Number:
0001104659-20-060287
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-12 18:25:50
Reporting Period:
2020-05-08
Accepted Time:
2020-05-12 18:25:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1554859 Semler Scientific Inc. SMLR Electromedical & Electrotherapeutic Apparatus (3845) 261367393
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1594346 E Daniel Conger C/O Semler Scientific, Inc.
911 Bern Court, Suite 110
San Jose CA 95112
Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-08 3,000 $2.59 3,000 No 4 M Direct
Common Stock Acquisiton 2020-05-08 10,000 $3.44 13,000 No 4 M Direct
Common Stock Disposition 2020-05-11 12,420 $40.11 580 No 4 S Direct
Common Stock Disposition 2020-05-11 580 $41.99 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-05-08 3,000 $0.00 3,000 $2.59
Common Stock Stock Option (Right to Buy) Disposition 2020-05-08 10,000 $0.00 10,000 $3.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-12-31 No 4 M Direct
0 2025-07-20 No 4 M Direct
Footnotes
  1. The price reported is a weighted average price. The shares were sold at prices ranging from $40.00 to $41.00. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  2. The price reported is a weighted average price. The shares were sold at prices ranging from $41.25 to $42.20. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. Fully vested and exercisable.